Canopy Growth Corp vs iShares MSCI France ETF — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while iShares MSCI France ETF trades at $45.48. The key difference: iShares MSCI France ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | EWQ | |
|---|---|---|
Market Cap | $398.46M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.92 | $48.35 |
52-Week Low | $0.86 | $41.43 |
Enterprise Value | $337.90M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
EWQ is currently trading at $44.83, down 0.47% on the day, with technical indicators showing a bearish trend as moving averages signal strong selling pressure. The stock faces resistance at $45 and support at $44, with oscillators remaining neutral. Recent corporate actions include a $1.09 dividend scheduled for payment in June 2026, providing income potential for long-term holders.
The outlook remains cautious due to technical weakness and European market volatility from ECB rate hikes and energy price pressures. Investment opportunity exists through dividend income, but risks include geopolitical tensions affecting European equities and potential short-squeeze volatility. The stock requires careful monitoring of European economic developments and technical breakout levels.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →